Dorsey Wright & Associates Sc Pharmaceuticals Inc. Transaction History

Dorsey Wright & Associates

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 26, 2023	BUY	$8.94 - $11.74 $2,950 - $3,874	330 Added 11.11%	3,300 $33,000
Q1 2023 Apr 19, 2023	SELL	$5.59 - $9.47 $1,844 - $3,125	-330 Reduced 10.0%	2,970 $26,000
Q4 2022 Feb 14, 2023	BUY	$4.02 - $7.53 $13,265 - $24,849	3,300 New	3,300 $23,000

37.5M

110K

12.1K

Ticker SCPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 27,402,100
Market Cap $91M
Description
scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for treatment of congestion in patients with heart failure. Its product p...

Get notified when there are updates to the investment portfolio of Dorsey Wright & Associates, based on Form 13F filings with the SEC.

Stay updated on Dorsey Wright & Associates with notifications on news.